This patent application claims priority to U.S. Provisional Patent Applications: 61/173,542 (filed Apr. 28, 2009), titled “Guidewire Support Catheter;” and 61/233,093 (filed Aug. 11, 2009), also titled “Guidewire Support Catheter.” The disclosures of these applications are incorporated herein by reference in their entirety.
This application may be related to U.S. patent application Ser. No. 12/108,433, titled “Catheter System and Method for Boring through Blocked Vascular Passages,” filed Apr. 23, 2008, and U.S. patent application Ser. No. 12/272,697, titled “Dual-tip Catheter System for Boring through Blocked Vascular Passages,” and filed Nov. 17, 2008. Both of these applications are herein incorporated by reference in their entirety.
All publications and patent applications mentioned in this specification are herein incorporated by reference in their entirety to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
Described herein are guidewire placement and support catheters that may be used to place a guidewire within an occluded lumen. In particular, described herein are guidewire placement and support catheters having a rotating, cutting and/or bending distal end region that may be used to position a guidewire through an occluded lumen of a vessel, including for treatment of chronic total occlusions.
Guidewire placement is a critical step in many medical procedures, particularly in minimally invasive procedures and treatment of vascular diseases. For example, a number of vascular diseases, such as coronary artery disease and peripheral vascular disease, are caused by the build-up of fatty atherosclerotic deposits (plaque) in the arteries, which limit blood flow to the tissues that are supplied by that particular artery. Disorders caused by occluded body vessels, including coronary artery disease (CAD) and peripheral artery disease (PAD) may be debilitating and life-threatening. Chronic Total Occlusion (CTO) can result in limb gangrene, requiring amputation, and may lead to other complications and eventually death. Increasingly, treatment of such blockages may include angioplasty or atherectomy procedures in which a guidewire, often via a catheter, is inserted into the diseased artery and threaded to the blocked region. There the blockage may be either squeezed into a more open position, for example, by pressure from an inflated catheter balloon (e.g., balloon angioplasty), and/or the blocked region may be held open by a stent. Alternatively a physician may use a catheter to surgically remove the plaque from the inside of the artery (e.g., an atherectomy).
Thus, placement of a guidewire completely or partially across the occlusion is often a critical, though difficult step. Devices and method for guidewire placement are expensive, complex, and all too often ineffective. A guidewire must typically be forced across or through the occlusion so that the treatment catheter may be positioned to treat the occluding plaque. The guidewire must be positioned across the plaque because the active (e.g., plaque removing or displacing) portions of most currently available catheters are usually located on the sides of the catheters. For example, stents, balloons, atherectomy cutting tools, and other active portions are usually mounted on the sides of the catheter.
However, when the artery is totally blocked by plaque, it is extremely difficult, and potentially dangerous to force the guidewire through the occlusion. An obstruction or plaque may be composed of relatively tough fibrous material, often including hard calcium deposits. Forcing a guidewire or catheter past such obstructions may cause the guidewire to exit the lumen of the vessel (e.g., artery), including causing it to enter the layers forming the artery, further damaging the tissue.
Currently available devices and methods for crossing occlusions are inadequate. For example, patents such as U.S. Pat. No. 5,556,405 to Lary, U.S. Pat. No. 6,152,938 to Curry, and U.S. Pat. No. 6,730,063 to Delaney et. al. describe devices and methods for passing an occlusion that do not adequately allow placement of a guidewire across a plaque. U.S. Pat. No. 5,556,405 teaches an incisor catheter having blades that can protrude from the catheter to push outward and form linear cuts in the plaque. Control of this device is mostly limited to extending/retracting the blades, and the cutting edges may damage the tissue, particularly if the blades contact the edges of the vessel; potentially exiting the lumen of the vessel. U.S. Pat. No. 6,152,938 describes a catheter drilling device for opening a wide variety of different blocked (occluded) tubes. The device anchors the tip of the drill head against a face of the occlusion, and partially rotates the drill head using a rein attached to the drill head so that the drill head faces at an angle. The blades of the drill are only controlled in rotation and may cut even non-target tissue, also leading the tip to exit and/or damage the vessel. As one alternative, U.S. Pat. No. 6,730,063 teaches a catheter device that can chemically treat calcified vascular occlusions by delivering acidic solutions and other fluids to calcified plaque to chemically dissolving the calcified material. As in the other known methods, this chemical treatment may be difficult to control, and in particular may be difficult to prevent damage to the vessel. Commercially available devices for treating occluded vessels include those marketed by Cordis Corporation, FlowCardia Technology, Kensey Nash Corporation, and other companies. These devices suffer from the same inadequacies as described above, and have also proven to have only limited success. The best reported success rates of overcoming CTOs with prior art devices range from 56% to 75%.
In addition, many of the devices and methods for crossing an occlusion described above may still require manually forcing the guidewire through the occlusion with only minimal (or no) assistance from the devices. Finally, many of these devices may inadvertently exit the vessel, but few, if any of them, are readily re-positionable to reenter the vessel.
A large family of patents and pending application including U.S. Pat. No. 6,001,112, U.S. Pat. No. 6,454,779, U.S. Pat. No. 6,206,898, U.S. Pat. No. 7,479,147, U.S. Pat. No. 6,451,036, U.S. Pat. No. 6,482,217, U.S. Pat. No. 7,172,610, U.S. Pat. No. 7,235,088 and U.S. Pat. No. 6,666,874 (“Taylor patents”) describe a rotatable cutter that is configured for atherectomy cutting. These devices typically include an inner rotating member (that may extend from a fixed housing at the distal end of the device). The device may be guided by a guidewire, and may include a vacuum source to remove cut material. However, these devices are not adapted to self-center. In addition, these blades are typically side-cutting, meaning that the cutting typically occurs at the sides, where the rotating blade may interact with a (typically fixed) complementary surface, cutting the tissue between the surfaces. Further, the distal rotating cutting head is smaller than the diameter of the rest of the elongate distal portion of the device.
Thus, there remains a need for guidewire positioning devices that can effectively traverse occluded vessels, and particularly chronically occluded vessels. Such devices would enable positioning of a guidewire and therefore enable positioning of stents and other devices to be more successfully used in high occlusion situations, leading to improved patient outcomes and a reduction in patient morbidity and mortality.
Described herein are guidewire positioning and support devices, method for using them, method of treating a subject using them, and systems including such guidewire positioning and support devices.
These devices typically include an active distal tip region that is rotatable and may include one or more wedges that may be extended from the rotatable distal tip. In some variations the distal end of the device may be steerable, and may be steered while still rotating the distal end of the device. The wedges may be fully or partially retracted into distal housing. Both the distal housing and the wedges may rotate. The wedges (which may be sharp blades or may be blunt) can be continuously extended from the distal housing and locked in any position (extended, partially extended or retracted) and rotated clockwise and/or counterclockwise while locked in a retracted, extended or partially extended position. The distal region of the device may also be controllable steered from the proximal end of the device. For example, the distal region of the device may be deflected. The bending distal region may be located immediately proximal to the rotatable distal tip. The device is typically elongate, and includes at least one lumen extending along the length (e.g., a central lumen) through which a guidewire may be passed. The lumen (or a separate lumen) may also be used to pass a material such as a contrast dye, saline, an imaging device, etc. The proximal end of the device typically includes a handle region that may be used to control the distal end. For example, the device may include a rotation control, a wedge extension control and/or a steering control. In some variations these controls may be combined into one or more controls or these functions may be distributed or divided between different controls. Any appropriate control may be used, including slides, knobs, dials, buttons, levers, switches, etc. In some variations the controls may be automated or computer-controlled. In some variations a driver (e.g., motor, mechanical driver, etc.) may be used to drive the controls. For example, rotation of the distal tip region may be driven by a motor, and may be geared or otherwise controlled. The rotation may be manually or automatically controlled.
In some variations, described in greater detail below, rather than an extendable wedge (or wedges) and a housing, the rotatable distal tip may a single integrated wedge having a protective surface that prevents cutting of tissue when rotated in a reverse direction, while allowing cutting of tissue when rotating in the reverse direction.
The wedges at the distal end may be referred to as a blade or blades, even though they may be substantially blunt. In some variations the wedges are configured so that they are forward-cutting, but not side-cutting. This means that they may include a forward-facing cutting edge, and the more lateral edges may be blunted or less sharp. In some variations the rotating distal tip includes only a single wedge, rather than multiple wedges. The wedge (blade) may be helically arranged at the distal tip. In many variations (including those illustrated below), the rotating distal tip including the wedge(s) had a diameter that is equal to (or greater than) the diameter of the rest of the elongate body (including the regions more proximal to the distal end of the device.
In some variations, the rotating distal end comprises three or more wedges that are radially separated around the tip region (e.g., spaced equally apart radially). It may be advantageous to have three or more wedges spaced around the tip, which may improve centering of the device, as described herein.
In operation, many of the devices described herein are self-centering within the lumen of the vessel. The self-centering property of the device arises from the configuration of the distal tip as well as the rotational properties of the device. In particular, as mentioned, the wedges may be blunt, or laterally blunt (having only a forward-cutting face). Further, both the wedges at the rotating distal portion and the housing into which the wedges may be extended or retracted may rotate. Finally, the diameter of the rotating distal end (including the wedges) may be at least equal to the diameter of the more proximal regions of the elongate body of the device which may also allow self-centering within the lumen of a vessel.
In general, the guidewire positioning and support catheter devices described herein may be referred to as “guidewire support catheters,” “guidewire positioning catheters,” “guidewire steering catheters,” “steerable rotating wedge” catheters, or the like. For simplicity, these guidewire positioning and support catheters may be referred to as merely “the devices” or “the catheter devices”.
The guidewire positioning and support devices described herein may be configured as single-use, over-the-wire device, devices. For example, the device may be compatible other guidewires of standard sizes used in minimally invasive procedures. The outer diameter of the elongate device (including the distal end region) may fit within a 7F sheath. The devices may be used with any appropriate guidewire, including steerable guidewires. For example, the guidewire may be a 0.035″ guidewire. These devices may generally be described as “steering” a guidewire, although they may be used with a guidewire within the catheter, or the guidewire may be positioned within the device after the catheter has been positioned.
In general, these devices provide support and guidance for positioning a guidewire across an occlusion. As described herein, the devices may support probing and exchange of an assortment of guidewires, by traversing an occluding in a vessel. In addition, the devices described herein may be used to deliver contrast. The internal lumen which may be used by the guidewire may also be used for local dye injections without removing the device from the vessel.
As described in greater detail below, in operation the steerable (deflecting) distal end and the rotating distal tip allow the device to be passed through an occlusion such as a plaque occluding a blood vessel (or artery) without requiring removal of the plaque. Thus, the device may be used to bluntly form a pathway through a plaque using the retractable/extendable rotating wedges at the distal tip, or simply using the rotating distal tip alone. The exposable wedge(s) at the distal tip may also allow for helical AND blunt microdissection. In some variations, the wedges at the distal tip are sharp (e.g., cutting or knife-edged), while in other variations the wedges are substantially blunt. The wedges are typically curved around or along the longitudinal axis of the distal tip. For example, a wedge may extend helically around the distal tip end of the device (when extended).
In variations in which the rotatable distal tip includes one or more separate wedge and housing, the extension of the wedge from the distal housing may be limited. For example, the wedges may be prevented from extending fully out of the distal housing, thereby preventing material (such as a plaque or tissue) from getting caught between the wedges and the housing.
The steerable distal end region may be steerable in any appropriate manner. In particular, the distal end region may be steerable by defecting in one direction (e.g., ‘down’) or in more than one direction (e.g., down/up, right/left, etc.). The degree of deflection may also be controlled. In some variations, the tip may be deflected a maximum of 10 degrees, 15 degrees, 20 degrees, 25 degrees, 30 degrees, 45 degrees, 60 degrees, 90 degrees, or any angle there between. In some variations the distal end region of the device is pre-biased to be straight. Therefore the straight configuration of the distal tip may be restored once the deflection (controlled at the proximal end) is restored. In addition to be deflectable, in some variations the distal end of the device is flexible. The end region may include the tip (e.g., the rotating tip) or it may include the region immediately proximal to the tip. In general the “tip region” refers to the rotatable tip region at the distal end.
Deflection or steering of the distal end may help with re-entry of the device. For example, the deflectable/steerable distal end region (which may be referred to as the “steerable tip”) may allow the catheter to re-enter the true lumen of the vessel if it becomes subintimal (e.g., if it extends into the fascia or region around the vessel).
In some variations, the device may include a distal end that has exposable bilateral wedges within a bullet-shaped housing, a catheter shaft, and a proximal handle that allows manipulation of the distal end of the device (e.g., rotation, steering, etc.) and may also provide a channel for flushing of the catheter lumen. In this variation (and other variations) both the distal tip and bilateral wedges are visible through fluoroscopy, and the catheter can be delivered over-the-wire through a 7F introducer sheath. The device also facilitates the delivery and exchange of guidewires and other therapeutic devices, such as stents, angioplasty balloons, or atherectomy catheters. It may also be used to deliver saline or contrast.
The proximal handle may act as an interface with the operator, and allows a physician to expose or retract the wedges as needed. This part of the device may include four main components: a rotator, a pin, a slider, and a luer. The operator can use the slider and rotator to manipulate the pin, which in turn controls whether the wedges are exposed or retracted. The pin acts as a locking mechanism to control the deployment of the wedges. At the end of the handle, the luer allows for flushing of the catheter with saline prior to use and serves as a portal to deliver contrast or saline to a desired area. The catheter shaft provides pushability and torque to the bilateral wedges, and serves to center the device towards the middle of a CTO. The distal tip contains the bilateral wedges within a bullet-shaped housing (
Any of the devices describe herein may include one or more of the following features, including: a steerable distal end region, a relatively short length, an elongate torque (drive) shaft) for rotating the distal tip, and reversible and retractable wedges having limited extension. The steerable distal end region is designed for and allows luminal re-entry. For example, the may be adjustable up to a 45° angle and can help orient the device.
The devices described herein may be any appropriate length, but relatively short length catheters may be particularly useful. For example, the device may be approximately 100 cm, allowing the device to reach any occlusion down to the popliteal and ease physician handling outside the body. In other variations, the device is between about 50 and 150 cm, between about 70 and 120 cm, etc.
The distal tip may be driven by an elongate drive short (or “torque shaft”) that extends the length of the device. This drive shaft is typically robust, allowing increased torque precision and manipulation during the operation. Examples of this torque shaft are provided herein. For example, the torque shaft may be made of a braided stainless steel material having a hollow lumen (forming the central lumen of the device). Rotation of the drive shaft typically drives the distal tip rotation. The drive shaft is typically flexible and connects to the rotational control at the proximal end (e.g., handle).
The extendable/retractable wedges (including the wedge element as well as the housing into which the wedges may be retracted) may include one or more features which act as safety features. For example, the (typically helical) wedges may be configured to disengage more readily if needed during operation of the device. The distal tip, including the wedges and housing, may rotate both clockwise and counterclockwise. In addition the wedges may be extended or retracted independently of the rotation. Thus, the distal end may be rotated with the wedges locked in any desired extended or retracted position. In addition the extension of the wedges may be limited to maximum extension that prevents the formation of a gap or space between the housing and the wedges between which material may be trapped. For example, the wedges may be prevented from further extension by a lock or pin that prevents the wedges from fully extending out of the housing.
The handle region at the proximal end of the device may also be adapted for handheld use. In particular, the controls at the handle region may be adapted so that the device may be manipulated by a single hand. In some variations the handle region may also include one or more indicators or displays for displaying the status of the distal end of the device. For example, the handle may include an indicator indicating the extent to which the wedges are extended from the distal tip. The indicator may be a dial, slider, or the like. The indicator may be marked or unmarked.
As mentioned, in some variations the wedge(s) may be extended to any degree (or to a maximum extension), or retracted completely. The handle, or the controller for the extension/retraction on the handle, may include a lock locking the wedges at a desired extension. The same, or a different, lock may also be included on the handle for locking the configuration/position of the distal end region that is steerable or deflectable. For example, a lock may be used to lock the distal end at a 45 degree angle.
The proximal handle may be otherwise configured to be handheld. For example, the controls may be clustered or located at one end of the handle with a gripper region at the other end. For example, the controls may be clustered at the proximal portion of the handle (allowing the distal portion of the handle to be gripped in the palm of the hand, and manipulated by the thumb and forefinger of the right.
In general, the elongate outer sheath of the catheter is flexible, and may be coated so that it can be readily inserted into a lumen of a sheath, catheter, or directly into a body lumen. For example, the elongate outer sheath of the catheter may be formed of a braided stainless steel, a polymer, or the like. The elongate outer sheath is typically tubular, and may be coated (either or both inner and outer diameter) with a protective cover. The elongate outer sheath may be referred to as a shaft (e.g., catheter shaft), and may be coated with a lubricious material or may be formed of a smooth and/or lubricious material.
Described herein are devices, including at least one specific example of a device, including some examples in which dimensions are provided. It is to be understood that these dimensions may be varied while staying within the scope of the invention as generally described. Unless otherwise indicated, these dimensions are intended as merely illustrative, and not limiting.
As mentioned briefly above, various aspects of the devices described herein provide substantially benefits compared to other device which may be used in occluded vessels, including rotating devices. For example, the forward cutting blades may prevent cutting on the sides/walls of the lumen. This configuration may also help with self-centering, as mentioned. In addition, the device may be configured so that the diameter of the blade (e.g., wedge) region is the same as the diameter of the rest of the catheter. Thus, the diameter of the distal end having the rotatable wedge is maxed out, so that the blades are as big across as the rest of the catheter, which may allow for maximum traction in the lumen of the vessel. The diameter of the blades (the distal region including the blade or blades) may therefore be equal to the diameter of the catheter. This in turn may allow the blades to engage better with the tissue of the vessel because there is more region of the vessel (e.g., width) available for the blade to engage with.
As mentioned, the distal end region may be rotated manually. For example, the tip may be spun or rotated by rotating a control or portion of the proximal handle. Thus, the device may be used as a screwdriver or drill element that is manually turning at a slow, more controlled (e.g., continuously and manually variable) rate. This may also provide tactile feedback to the operator, who can gauge how much force is applied by the feel of the device. For example, a clinician may determine how much force to apply both to advance and to spin the blades. Compared to true “drilling” elements and augering devices, the devices described herein may be worked into the media of the vessel more readily. Rotation of the tip may be clockwise or counterclockwise. In some variations the direction of rotation determines whether the wedge(s) at the distal tip are cutting or non-cutting. The user may alter the direction of cutting at any time during the procedure, and may manually or automatically control the rate and/or direction.
In variations having blades (wedges) that are substantially blunt on the longitudinal side (e.g. the side facing the wall of the vessel), the devices may advantageously be advanced into the vessel, and may self-centered. These variations may also prevent damaging the lumen of the vessel.
In variations of the devices having a steerable distal end, the same control that allows extension (and/or rotation) of the distal end to extended/retract the wedges from the catheter/protective housing may be used to steer (e.g., bend) the distal end. By combining the steering with blade extension, the controls are simplified, allowing the device to be controlled more easily with a single activation scheme.
In addition, these devices realize previously unexpected advantages because the entire distal end, including (in some variations) the housing into which the wedges/blades may retract, rotates. The rotation of the distal protective housing may permit blunt tip movement/dissection and allows powered blunt dissection. Compared to simply advancing a blunt (non-rotating tip) through the vessel, rotating the blunt or blunted distal end (e.g., when the blades are retracted into the housing), the device may exhibit a substantial mechanical advantage, apparently allowing the device to overcome the static friction at the tip and advance across an occlusion. As mentioned above, the rotating housing also helps with self-centering and steering of the device. The ability to rotate the device in both the clockwise and counterclockwise (e.g., forward and backward) directions manually is also particularly helpful for blunt dissection. Turning the catheter tip (with blades retracted) in one direction (i.e., clockwise) allows the helical slots to engage the tissue more as the edges are rotated in the direction of the helix, rather than the opposite direction (i.e., counterclockwise) that moves it along the direction of the helix, thereby preventing or allowing less motion forward.
Finally, the devices described herein can be locked in the open/closed position while still being rotatable. For example, the devices can be locked with the wedges/blades partially extended, completely extended, and/or completely retracted. In many variations the handle includes a lock or locking control for securing the blades/wedges in a particular extension, while still allowing the entire distal end (including the blades/wedges and housing) to rotate.
Also described herein are elongate guidewire support catheter devices for positioning a guidewire across an occluded portion of a vessel including: an elongate catheter body having an outer diameter; a rotatable distal tip configured to be rotated in a forward direction to cut tissue and a reverse direction for bluntly contacting tissue without cutting; a proximal handle region including a control for rotating the distal tip in either the forward or reverse directions; and a central lumen extending through the elongate guidewire support catheter configured to pass a guidewire.
The outer diameter of the distal tip may be approximately the same as the outer diameter of the elongate catheter body.
In some variations, the device also includes a steerable distal end region configured to controllably deflect the rotatable distal tip. The rotatable tip may comprise a helical blade edge. The rotatable distal tip in some variations has a substantially smooth, curved outer surface that presents an atraumatic tissue-contacting surface when rotated in the reverse direction and that presents a sharp, tissue-cutting surface when rotated in the forward direction.
Also described herein are methods of placing a guidewire across an occlusion of the lumen of a blood vessel including the steps of: advancing a catheter having an elongate catheter body and a rotatable distal tip towards the occlusion in the lumen of the blood vessel (wherein the distal tip comprises a forward-cutting wedge having atraumatic lateral edges and a protective housing); rotating and extending the wedge of the distal tip out of the protective housing while rotating both the wedge and the protective housing (wherein the wedge and protective housing have an outer diameter at least as large as the outer diameter of the elongate catheter body); advancing the distal tip across the occlusion; and passing a guidewire through a lumen of the catheter once it has crossed at least partially through the occlusion.
The step of rotating the distal tip of the catheter may include rotating the distal tip both clockwise and counterclockwise.
The method may also include steering the distal tip. The step of steering may include manipulating a control on the handle of the catheter to bend the distal end of the device.
Also described herein are methods of placing a guidewire across an occlusion of the lumen of a blood vessel including: advancing a catheter having an elongate catheter body and a rotatable distal tip towards the occlusion in the lumen of the blood vessel; rotating the distal tip relative to the elongate body in a forward direction to cut tissue rotating the distal tip relative to the elongate body in a reverse direction to bluntly contacting tissue without cutting; advancing the distal tip across the occlusion; and passing a guidewire through a lumen of the catheter once it has crossed at least partially through the occlusion.
The step of rotating the distal tip may comprise manually rotating the distal tip. The method may also include steering the distal tip. As mentioned, the step of steering may include manipulating a control on the handle of the catheter to bend the distal end of the device.
One example of such a guidewire support catheter is provided below, although other variations are contemplated. In general, these devices include a rotatable distal tip. The distal tip may be rotated manually (by operation of a control on the proximal handle). In some variations both counterclockwise and clockwise rotation is possible. The devices may include one or more extendable wedges that may be extended from or retracted into a distal housing that is atraumatic (e.g., smooth, non-sharp). The wedges may be blades, or they may include one or more sharp regions, or they may be dull. The wedges may be extended continuously, so that the user can operate a control on the proximal handle to extend and/or retract the wedges. The wedge or wedges may extend laterally from the region along the length of the tip. For example, the wedges may extend helically at least partially around the distal tip. In some variations a single wedge (which may be a single helical wedge) extends from the tip of the distal end. Multiple wedges may extend from the distal tip. In some variations two bilateral wedges may extend from the distal tip. The rotation of the wedges may be independent of the extension of the distal tip. For example, the distal tip may be rotated even with the wedges retracted or with the wedges all or completely extended.
The devices described herein may also include a steerable distal end region. The steerable distal end region may be steerable in one or more directions. For example, the steerable distal tip may be displaced in one direction (e.g., bent in one direction). In some variations, the steerable distal end region is coordinated with the extension of the wedge or wedges from the distal tip. For example the steerable distal end region may be configured to bend in one or more direction using the same actuator that extends the wedge from the rotatable distal tip. This configuration may reduce or eliminate the need for an additional bending/steering mechanism (e.g., tendon wires or the like) to traverse the elongate body of the catheter. In other variations, including those allow for steering in multiple directions the steering of the distal end region may be independent of the extension of the wedge from the distal tip. For example, one or more control wires (e.g., tendons), hydraulic or pressure lines may be use to control steering (bending) of the distal end region.
The blunt distal tip 101 houses one or more deployable spiral wedges (not visible in
The handle assembly 120 typically consists of a handle body 105, a rotator 107, a tip indicator 109, a slider 111, a slider lock 113, and a luer 117. The handle body 120 controls rotational orientation of the catheter, including the flexible distal tip. The rotator 107 controls the rotational movement to the distal tip independent of the catheter orientation. Rotational movement of the distal tip 101 can be achieved either with wedges deployed or retracted. As referenced above, the slider 111 can move through the rotator in a longitudinal direction to control wedge deployment/retraction and the amount of tip deflection. The slider lock 113 restricts the slider movement. The slider lock 113 can be engaged by turning it in the clockwise direction until tight, and can be disengaged by counterclockwise rotation. The Luer is provided to facilitate fluid flush and the entry/exit of the guidewire. This port also acts as an entry port for the guidewire.
In the variation shown in
Although the control of the extension/retraction of the wedges and the deflection or steering of the distal tip are conjoined in this example, which may simplify the one-handed control of the catheter and allow the control of extension/retraction and deflection using a single drive shaft, in other variations these controls may be separated, and separate drive shafts may be used. In addition, the deflecting/bending tubular region 46, which may be referred to as the deflecting, bending or hinged region, is configured to bend by the application of a longitudinal pushing force that is applied from the drive shaft in this example. Because this deflecting region is ‘hinged’ on one side in this example, a symmetric (or even asymmetric) force applied across the region causes the region to bend against the hinge. The tubular region 46 in this example may be made of any appropriate material, for example, metal (stainless steel, shape memory alloys such as Nitinol, or the like), polymers (plastics, elastomers, etc.) or the like. It may be helpful if the region is configured to include a restoring force and restores itself to the original (straight) shape when the distal force is removed.
FIGS. 3 and 4A-4C illustrate steering of the distal end of a catheter as just discussed. For example, in
The handle region 210 includes a handle body 41 that is connected to a handle body cap 44 which interfaces with a rotator portion 56. The rotator 56 partially covers a slider 54. The rotator portion 56 may be rotated; this rotation is translated (e.g., via a drive shaft) into rotation of the distal tip. The slider may move distally or proximally within the handle 120. A window in the slider shows a position indicator (set screw 55) that indicates the longitudinal position of the slider, and therefore indicates the extension/retraction state of the wedges at the distal tip. Sliding the slider distally extends the wedges from the housing and may also deflect or steer the device, as just described. The proximal end of the device includes a luer fitting region which may be used to connect to the central lumen of the device (e.g., for applying contrast, saline, etc.). The luer region may include a threaded or lockable region. The luer region may also include a flanged or funnel-shaped opening to help assist in threading a guidewire into the catheter.
In addition to the seals, a locking member 57 configured as a screw-lock, may be included on at least the slider portion of the device. This lock may be used (e.g., locking by screwing distally/unscrewing proximally to unlock) to secure the slider in a desired position. Thus, the position of the wedges (extended/retracted position) and/or the deflection of the distal end may be locked in a desired position. Other locks (e.g., preventing or allowing rotation) may also be included.
Each of the various components shown in the exploded views of FIGS. 7 and 9A-9B are illustrated in greater detail in
Methods of Use
In operation, any of the devices described herein may be used to treat an occlusion. In particular, these devices may be used to position a guidewire across an occlusion such as a chronic total occlusion of the peripheral vascular system. In general, treatment may include insertion of the catheter device into a vessel (e.g., blood vessel or artery) that is occluded. Fluoroscopy or other imaging technique may be used to visualize both the device and the vessel. Thus, appropriate contrast material may be used, and may be applied through the device or prior to insertion of the device. The device may be inserted using known minimally invasive (e.g., percutaneous) techniques. The device may be inserted with the wedge element retracted, so that the distal tip region is essentially atraumatic, to prevent damage to tissue or miss-guidance of the device.
The device may be positioned against the occlusion, and the distal tip region may be rotated with or without the wedge element deployed. The deploying the wedge element, in combination with the (manual) rotation may allow the device to penetrate the occlusion. The device may thus be advanced by rotation of the distal tip, either with or without the wedge element extended. The catheter may be gently driven (e.g., by the medical professional) distally to advance the device. The device may be used prior to insertion of a guidewire through the device, or it may be used in conjunction with a guidewire. For example, a guidewire may be extended from the distal end as it is advanced to also help penetrate the occlusion or steer the device.
The distal region of the device may also be steered by controlling the bending of the flexible distal region, as illustrated and described above. If the device should penetrate or exit the lumen of the vessel, it may be guided back into the vessel (re-entry) using the steerable distal end.
For example, in operation, a catheter may be removed from a sterile package and transfer to a sterile field where it can be first flushed with heparanized saline through the proximal port located on the handle assembly. The catheter may then be lightly wiped with heparanized saline in preparation for insertion. Before use, the catheter may be tested to confirm that the wedges extend and retract and the distal end region of the device bends for steering. In general, to control the device, the rotator may be turned clockwise and counterclockwise to rotate the distal tip region. The slider may be longitudinally slide distally to extend the wedges from the tip region (from out of the housing) and further distally to bend the steerable distal end region. The slider may then be slid proximally to ‘unbend’ (restore to straight) the distal end, and to retract the wedge region. The slider lock may be rotated clockwise to engage (lock) the slider in position (and therefore the extension of the wedge(s) and the bend of the distal end region, and the slider lock may be rotated counterclockwise to disengage and allow longitudinal slider movement.
The device may be inserted into the vessel by first retracting the wedges into the housing at the distal tip. Prior to inserting the catheters describe herein, a guidewire may be inserted up to (or adjacent to) the occlusion using standard techniques. The catheter may then be advanced over the guidewire under fluoroscopic guidance through a sheath to the target lesion (occlusion). In operation, the guidewire support catheter is used with a guidewire within the central lumen, which may provide additional stiffness and support to the catheter.
When the device is positioned, manually torque and advance the catheter through a region of the peripheral vasculature while maintaining catheter position at the lesion site. If additional support is necessary to advance beyond the region, deploy the wedges by pushing on the slider the slider lock may be engaged if desired. The rotator may be manipulated as needed to advance the catheter. To ensure the distal tip of the device remains in the vessel's true lumen, the Slider may be pushed until the tip is positioned properly and engage the slider lock.
After advancing beyond the lesion, the wedges may be fully retracted under fluoroscopic guidance, and the catheter may be retracted, leaving the guidewire in place.
For example, any of the catheters described herein (referred to for convenience as a “Wildcat” device) may be used to treat peripheral vascular disease. When used to treat chronic total occlusions, the manually rotatable distal end (including the wedges) of the catheter may have been found to guide the catheter in the true lumen, especially when the reaching the distal cap of a lesion. Centering (self-centering) of the catheter appears to result from the rotation of the blades, coupled with the dimension of the device, including the diameter of the wedges and distal tip (which are typically the same as the diameter of the rest of the catheter). This rotating distal tip helps the device to stay in true lumen of the blood vessel. The blades (wedges) are configured to engage and dissect their way through tissue like the atheroma. For example, the rotating blades may create a sweeping path that is not only self-centering, but also is much bigger than the vessel wall (media). If a blade does engage with the media, it returns in the true lumen because the configuration of the device may help keep it within that space. As mentioned, the wedges may include a forward-cutting face (e.g., a blade or sharp edge that faces distally, away from the lateral sides, and therefore away from the walls of the lumen). The lateral portions of the wedge may be atraumatic, so that they don't cut or tear the lumen tissue. An atraumatic wedge portion may be rounded or otherwise dulled and configured so as not to cut the lumen. In some variations more than one wedge (e.g., two or more wedges) may be used. Thus, when one blade (wedge) is engaged with the vessel wall, the other blade continues making its way through the atheroma.
If the catheter device does end up in the sub-intimal plane (e.g., false lumen), as illustrated in
The variation shown in
Any of the variations described herein may include one, two, three, or more wedges in the distal tip. It may be advantageous for the device to include three or more wedges that extend from the distal end. Having three or more wedges positioned around the distal end of the device may permit more equal distribution of the forces around the center of the tip. In addition, having three or more wedge may enhance the centering capability of the device. Devices having two wedges may engage the target tissue with only a single wedge at a time (e.g., in a lumen that is larger in diameter then the diameter of the device), which may cause the device to tend to spin around the engaged wedge or blade rather than the center of the device (e.g., the true center point of the catheter). For example,
In operation, the variation shown in
The examples and illustrations included herein show, by way of illustration and not of limitation, specific embodiments in which the subject matter may be practiced. Other embodiments may be utilized and derived there from, such that structural and logical substitutions and changes may be made without departing from the scope of this disclosure. Such embodiments of the inventive subject matter may be referred to herein individually or collectively by the term “invention” merely for convenience and without intending to voluntarily limit the scope of this application to any single invention or inventive concept, if more than one is in fact disclosed. Thus, although specific embodiments have been illustrated and described herein, any arrangement calculated to achieve the same purpose may be substituted for the specific embodiments shown. This disclosure is intended to cover any and all adaptations or variations of various embodiments. Combinations of the above embodiments, and other embodiments not specifically described herein, will be apparent to those of skill in the art upon reviewing the above description.
Number | Name | Date | Kind |
---|---|---|---|
4178935 | Gekhaman et al. | Dec 1979 | A |
4552554 | Gould et al. | Nov 1985 | A |
4621353 | Hazel et al. | Nov 1986 | A |
4639091 | Huignard et al. | Jan 1987 | A |
4654024 | Crittenden et al. | Mar 1987 | A |
4686982 | Nash | Aug 1987 | A |
4771774 | Simpson et al. | Sep 1988 | A |
4926858 | Gifford, III et al. | May 1990 | A |
5000185 | Yock | Mar 1991 | A |
5047040 | Simpson et al. | Sep 1991 | A |
5085662 | Willard | Feb 1992 | A |
5182291 | Gubin et al. | Jan 1993 | A |
5190050 | Nitzsche | Mar 1993 | A |
5192291 | Pannek, Jr. | Mar 1993 | A |
5312415 | Palermo | May 1994 | A |
5312425 | Evans et al. | May 1994 | A |
5321501 | Swanson et al. | Jun 1994 | A |
5333142 | Scheps | Jul 1994 | A |
5358472 | Vance et al. | Oct 1994 | A |
5383460 | Jang et al. | Jan 1995 | A |
5383467 | Auer et al. | Jan 1995 | A |
5429136 | Milo et al. | Jul 1995 | A |
5431673 | Summers et al. | Jul 1995 | A |
5459570 | Swanson et al. | Oct 1995 | A |
5465147 | Swanson | Nov 1995 | A |
5556405 | Lary | Sep 1996 | A |
5632754 | Farley et al. | May 1997 | A |
5632755 | Nordgren et al. | May 1997 | A |
5674232 | Halliburton | Oct 1997 | A |
5681336 | Clement et al. | Oct 1997 | A |
5690634 | Muller et al. | Nov 1997 | A |
5722403 | McGee et al. | Mar 1998 | A |
5795295 | Hellmuth et al. | Aug 1998 | A |
5807339 | Bostrom et al. | Sep 1998 | A |
5830145 | Tenhoff | Nov 1998 | A |
5843050 | Jones et al. | Dec 1998 | A |
5868778 | Gershony et al. | Feb 1999 | A |
5872879 | Hamm | Feb 1999 | A |
5904651 | Swanson et al. | May 1999 | A |
5907425 | Dickensheets et al. | May 1999 | A |
5935075 | Casscells et al. | Aug 1999 | A |
5938602 | Lloyd | Aug 1999 | A |
5951482 | Winston et al. | Sep 1999 | A |
5951581 | Saadat et al. | Sep 1999 | A |
5951583 | Jensen et al. | Sep 1999 | A |
5956355 | Swanson et al. | Sep 1999 | A |
5957952 | Gershony et al. | Sep 1999 | A |
6001112 | Taylor | Dec 1999 | A |
6007530 | Dornhofer et al. | Dec 1999 | A |
6010449 | Selmon et al. | Jan 2000 | A |
6013072 | Winston et al. | Jan 2000 | A |
6017359 | Gershony et al. | Jan 2000 | A |
6027514 | Stine et al. | Feb 2000 | A |
6048349 | Winston et al. | Apr 2000 | A |
6080170 | Nash et al. | Jun 2000 | A |
6106515 | Winston et al. | Aug 2000 | A |
6110164 | Vidlund | Aug 2000 | A |
6120515 | Rogers et al. | Sep 2000 | A |
6120516 | Selmon et al. | Sep 2000 | A |
6134002 | Stimson et al. | Oct 2000 | A |
6134003 | Tearney et al. | Oct 2000 | A |
6152938 | Curry | Nov 2000 | A |
6152951 | Hashimoto et al. | Nov 2000 | A |
6160826 | Swanson et al. | Dec 2000 | A |
6175669 | Colston et al. | Jan 2001 | B1 |
6193676 | Winston et al. | Feb 2001 | B1 |
6206898 | Honeycutt et al. | Mar 2001 | B1 |
6228076 | Winston et al. | May 2001 | B1 |
6241744 | Imran et al. | Jun 2001 | B1 |
6283957 | Hashimoto et al. | Sep 2001 | B1 |
6290668 | Gregory et al. | Sep 2001 | B1 |
6294775 | Seibel et al. | Sep 2001 | B1 |
6299622 | Snow et al. | Oct 2001 | B1 |
6307985 | Murakami et al. | Oct 2001 | B1 |
6402719 | Ponzi et al. | Jun 2002 | B1 |
6445939 | Swanson et al. | Sep 2002 | B1 |
6445944 | Ostrovsky | Sep 2002 | B1 |
6447525 | Follmer et al. | Sep 2002 | B2 |
6451036 | Heitzmann et al. | Sep 2002 | B1 |
6454779 | Taylor | Sep 2002 | B1 |
6482217 | Pintor et al. | Nov 2002 | B1 |
6485413 | Boppart et al. | Nov 2002 | B1 |
6497649 | Parker et al. | Dec 2002 | B2 |
6501551 | Tearney et al. | Dec 2002 | B1 |
6503261 | Bruneau et al. | Jan 2003 | B1 |
6517528 | Pantages et al. | Feb 2003 | B1 |
6542665 | Reed et al. | Apr 2003 | B2 |
6551302 | Rosinko et al. | Apr 2003 | B1 |
6563105 | Seibel et al. | May 2003 | B2 |
6564087 | Pitris et al. | May 2003 | B1 |
6565588 | Clement et al. | May 2003 | B1 |
6572643 | Gharibadeh | Jun 2003 | B1 |
6579298 | Bruneau et al. | Jun 2003 | B1 |
6615071 | Casscells, III et al. | Sep 2003 | B1 |
6623496 | Snow et al. | Sep 2003 | B2 |
6638233 | Corvi et al. | Oct 2003 | B2 |
6645217 | MacKinnon et al. | Nov 2003 | B1 |
6666874 | Heitzmann et al. | Dec 2003 | B2 |
6687010 | Horii | Feb 2004 | B1 |
6728571 | Barbato | Apr 2004 | B1 |
D489973 | Root et al. | May 2004 | S |
6730063 | Delaney et al. | May 2004 | B2 |
6760112 | Reed et al. | Jul 2004 | B2 |
6800085 | Selmon et al. | Oct 2004 | B2 |
6818001 | Wulfman et al. | Nov 2004 | B2 |
6824550 | Noriega et al. | Nov 2004 | B1 |
6830577 | Nash et al. | Dec 2004 | B2 |
6845190 | Smithwick et al. | Jan 2005 | B1 |
6852109 | Winston et al. | Feb 2005 | B2 |
6853457 | Bjarklev et al. | Feb 2005 | B2 |
6856712 | Fauver et al. | Feb 2005 | B2 |
6867753 | Chinthammit et al. | Mar 2005 | B2 |
6879851 | McNamara et al. | Apr 2005 | B2 |
6947787 | Webler | Sep 2005 | B2 |
6961123 | Wang et al. | Nov 2005 | B1 |
6970732 | Winston et al. | Nov 2005 | B2 |
6975898 | Seibel | Dec 2005 | B2 |
7068878 | Crossman-Bosworth et al. | Jun 2006 | B2 |
7074231 | Jang | Jul 2006 | B2 |
7126693 | Everett et al. | Oct 2006 | B2 |
7172610 | Heitzmann et al. | Feb 2007 | B2 |
7235088 | Pintor et al. | Jun 2007 | B2 |
7242480 | Alphonse | Jul 2007 | B2 |
7261687 | Yang | Aug 2007 | B2 |
7288087 | Winston et al. | Oct 2007 | B2 |
7291146 | Steinke et al. | Nov 2007 | B2 |
7297131 | Nita | Nov 2007 | B2 |
7311723 | Seibel et al. | Dec 2007 | B2 |
7344546 | Wulfman et al. | Mar 2008 | B2 |
7366376 | Shishkov et al. | Apr 2008 | B2 |
7382949 | Bouma et al. | Jun 2008 | B2 |
7426036 | Feldchtein et al. | Sep 2008 | B2 |
7428001 | Schowengerdt et al. | Sep 2008 | B2 |
7428053 | Feldchtein et al. | Sep 2008 | B2 |
7455649 | Root et al. | Nov 2008 | B2 |
7474407 | Gutin | Jan 2009 | B2 |
7485127 | Nistal | Feb 2009 | B2 |
7488340 | Kauphusman et al. | Feb 2009 | B2 |
7530948 | Seibel et al. | May 2009 | B2 |
7530976 | MacMahon et al. | May 2009 | B2 |
7538859 | Tearney et al. | May 2009 | B2 |
7538886 | Feldchtein | May 2009 | B2 |
7539362 | Teramura | May 2009 | B2 |
7542145 | Toida et al. | Jun 2009 | B2 |
7544162 | Ohkubo | Jun 2009 | B2 |
7545504 | Buckland et al. | Jun 2009 | B2 |
7555333 | Wang et al. | Jun 2009 | B2 |
7577471 | Camus et al. | Aug 2009 | B2 |
7583872 | Seibel et al. | Sep 2009 | B2 |
7616986 | Seibel et al. | Nov 2009 | B2 |
7674253 | Fisher et al. | Mar 2010 | B2 |
7706863 | Imanishi et al. | Apr 2010 | B2 |
7728985 | Feldchtein et al. | Jun 2010 | B2 |
7734332 | Sher | Jun 2010 | B2 |
7738945 | Fauver et al. | Jun 2010 | B2 |
7753852 | Maschke | Jul 2010 | B2 |
7785286 | Magnin et al. | Aug 2010 | B2 |
7813609 | Petersen et al. | Oct 2010 | B2 |
7821643 | Amazeen et al. | Oct 2010 | B2 |
7824089 | Charles | Nov 2010 | B2 |
7944568 | Teramura et al. | May 2011 | B2 |
7952718 | Li et al. | May 2011 | B2 |
8059274 | Splinter | Nov 2011 | B2 |
20010004700 | Honeycutt et al. | Jun 2001 | A1 |
20010020126 | Swanson et al. | Sep 2001 | A1 |
20020007190 | Wulfman et al. | Jan 2002 | A1 |
20020019644 | Hastings et al. | Feb 2002 | A1 |
20020077642 | Patel et al. | Jun 2002 | A1 |
20020082626 | Donohoe et al. | Jun 2002 | A1 |
20020111548 | Swanson et al. | Aug 2002 | A1 |
20020115931 | Strauss et al. | Aug 2002 | A1 |
20030028100 | Tearney et al. | Feb 2003 | A1 |
20030032880 | Moore | Feb 2003 | A1 |
20030045835 | Anderson et al. | Mar 2003 | A1 |
20030095248 | Frot | May 2003 | A1 |
20030097044 | Rovegno | May 2003 | A1 |
20030120295 | Simpson et al. | Jun 2003 | A1 |
20030125756 | Shturman et al. | Jul 2003 | A1 |
20030125757 | Patel et al. | Jul 2003 | A1 |
20030125758 | Simpson et al. | Jul 2003 | A1 |
20040039371 | Tockman et al. | Feb 2004 | A1 |
20040082850 | Bonner et al. | Apr 2004 | A1 |
20040092915 | Levatter | May 2004 | A1 |
20040147934 | Kiester | Jul 2004 | A1 |
20040167553 | Simpson et al. | Aug 2004 | A1 |
20040167554 | Simpson et al. | Aug 2004 | A1 |
20040181249 | Torrance et al. | Sep 2004 | A1 |
20040220519 | Wulfman et al. | Nov 2004 | A1 |
20040230212 | Wulfman | Nov 2004 | A1 |
20040230213 | Wulfman et al. | Nov 2004 | A1 |
20040236312 | Nistal et al. | Nov 2004 | A1 |
20040243162 | Wulfman et al. | Dec 2004 | A1 |
20040254599 | Lipoma et al. | Dec 2004 | A1 |
20050020925 | Kleen et al. | Jan 2005 | A1 |
20050043614 | Huizenga et al. | Feb 2005 | A1 |
20050054947 | Goldenberg | Mar 2005 | A1 |
20050085708 | Fauver et al. | Apr 2005 | A1 |
20050085721 | Fauver et al. | Apr 2005 | A1 |
20050141843 | Warden et al. | Jun 2005 | A1 |
20050154407 | Simpson | Jul 2005 | A1 |
20050159731 | Lee | Jul 2005 | A1 |
20050177068 | Simpson | Aug 2005 | A1 |
20050182295 | Soper et al. | Aug 2005 | A1 |
20050187571 | Maschke | Aug 2005 | A1 |
20050192496 | Maschke | Sep 2005 | A1 |
20050201662 | Petersen et al. | Sep 2005 | A1 |
20050222519 | Simpson | Oct 2005 | A1 |
20050222663 | Simpson et al. | Oct 2005 | A1 |
20050251116 | Steinke et al. | Nov 2005 | A1 |
20060032508 | Simpson | Feb 2006 | A1 |
20060046235 | Alexander | Mar 2006 | A1 |
20060064009 | Webler et al. | Mar 2006 | A1 |
20060084911 | Belef et al. | Apr 2006 | A1 |
20060109478 | Tearney et al. | May 2006 | A1 |
20060135870 | Webler | Jun 2006 | A1 |
20060229646 | Sparks | Oct 2006 | A1 |
20060229659 | Gifford et al. | Oct 2006 | A1 |
20060235366 | Simpson | Oct 2006 | A1 |
20060236019 | Soito et al. | Oct 2006 | A1 |
20060239982 | Simpson | Oct 2006 | A1 |
20060241503 | Schmitt et al. | Oct 2006 | A1 |
20060244973 | Yun et al. | Nov 2006 | A1 |
20060252993 | Freed et al. | Nov 2006 | A1 |
20060264741 | Prince | Nov 2006 | A1 |
20070010840 | Rosenthal et al. | Jan 2007 | A1 |
20070015969 | Feldman et al. | Jan 2007 | A1 |
20070015979 | Redel | Jan 2007 | A1 |
20070035855 | Dickensheets | Feb 2007 | A1 |
20070038061 | Huennekens et al. | Feb 2007 | A1 |
20070038173 | Simpson | Feb 2007 | A1 |
20070078469 | Soito et al. | Apr 2007 | A1 |
20070196926 | Soito et al. | Aug 2007 | A1 |
20070255252 | Mehta | Nov 2007 | A1 |
20070270647 | Nahen et al. | Nov 2007 | A1 |
20070276419 | Rosenthal | Nov 2007 | A1 |
20070288036 | Seshadri | Dec 2007 | A1 |
20070299309 | Seibel et al. | Dec 2007 | A1 |
20080004643 | To et al. | Jan 2008 | A1 |
20080004644 | To et al. | Jan 2008 | A1 |
20080004645 | To et al. | Jan 2008 | A1 |
20080004646 | To et al. | Jan 2008 | A1 |
20080015491 | Bei et al. | Jan 2008 | A1 |
20080027334 | Langston | Jan 2008 | A1 |
20080033396 | Danek et al. | Feb 2008 | A1 |
20080045986 | To et al. | Feb 2008 | A1 |
20080058629 | Seibel et al. | Mar 2008 | A1 |
20080065124 | Olson | Mar 2008 | A1 |
20080065125 | Olson | Mar 2008 | A1 |
20080065205 | Nguyen et al. | Mar 2008 | A1 |
20080103439 | Torrance et al. | May 2008 | A1 |
20080103446 | Torrance et al. | May 2008 | A1 |
20080103516 | Wulfman et al. | May 2008 | A1 |
20080139897 | Ainsworth et al. | Jun 2008 | A1 |
20080147000 | Seibel et al. | Jun 2008 | A1 |
20080154293 | Taylor et al. | Jun 2008 | A1 |
20080186501 | Xie | Aug 2008 | A1 |
20080221388 | Seibel et al. | Sep 2008 | A1 |
20080228033 | Tumlinson et al. | Sep 2008 | A1 |
20080243030 | Seibel et al. | Oct 2008 | A1 |
20080243031 | Seibel et al. | Oct 2008 | A1 |
20080262312 | Carroll et al. | Oct 2008 | A1 |
20090018565 | To et al. | Jan 2009 | A1 |
20090018566 | Escudero et al. | Jan 2009 | A1 |
20090018567 | Escudero et al. | Jan 2009 | A1 |
20090024085 | To et al. | Jan 2009 | A1 |
20090024191 | Seibel et al. | Jan 2009 | A1 |
20090028407 | Seibel et al. | Jan 2009 | A1 |
20090073444 | Wang | Mar 2009 | A1 |
20090093764 | Pfeffer et al. | Apr 2009 | A1 |
20090099641 | Wu et al. | Apr 2009 | A1 |
20090135280 | Johnston et al. | May 2009 | A1 |
20090137893 | Seibel et al. | May 2009 | A1 |
20090152664 | Tian et al. | Jun 2009 | A1 |
20090198125 | Nakabayashi et al. | Aug 2009 | A1 |
20090208143 | Yoon et al. | Aug 2009 | A1 |
20090216180 | Lee et al. | Aug 2009 | A1 |
20090221904 | Shealy et al. | Sep 2009 | A1 |
20090221920 | Boppart et al. | Sep 2009 | A1 |
20090235396 | Wang et al. | Sep 2009 | A1 |
20090244485 | Walsh et al. | Oct 2009 | A1 |
20090264826 | Thompson | Oct 2009 | A1 |
20090270888 | Patel et al. | Oct 2009 | A1 |
20090284749 | Johnson et al. | Nov 2009 | A1 |
20090316116 | Melville et al. | Dec 2009 | A1 |
20100049225 | To et al. | Feb 2010 | A1 |
20100130996 | Doud et al. | May 2010 | A1 |
20100241147 | Maschke | Sep 2010 | A1 |
20100253949 | Adler et al. | Oct 2010 | A1 |
20100292539 | Lankenau et al. | Nov 2010 | A1 |
20100292721 | Moberg | Nov 2010 | A1 |
20100312263 | Moberg et al. | Dec 2010 | A1 |
20100317973 | Nita | Dec 2010 | A1 |
20100324472 | Wulfman | Dec 2010 | A1 |
20110040238 | Wulfman et al. | Feb 2011 | A1 |
20110106004 | Eubanks et al. | May 2011 | A1 |
20110118660 | Torrance et al. | May 2011 | A1 |
20110130777 | Zhang et al. | Jun 2011 | A1 |
20110144673 | Zhang et al. | Jun 2011 | A1 |
20120041307 | Patel et al. | Feb 2012 | A1 |
20120046679 | Patel et al. | Feb 2012 | A1 |
20130096589 | Spencer et al. | Apr 2013 | A1 |
20130123615 | Spencer et al. | May 2013 | A1 |
20130138128 | Patel et al. | May 2013 | A1 |
Number | Date | Country |
---|---|---|
1875242 | Dec 2006 | CN |
1947652 | Apr 2007 | CN |
101601581 | Dec 2009 | CN |
202006018883.5 | Feb 2007 | DE |
1859732 | Nov 2007 | EP |
2353526 | Sep 2013 | EP |
2006-326157 | Dec 2006 | JP |
20070047221 | May 2007 | KR |
2185859 | Jul 2002 | RU |
2218191 | Dec 2003 | RU |
WO 9117698 | Nov 1991 | WO |
WO 9923958 | May 1999 | WO |
WO 0054659 | Sep 2000 | WO |
WO 0176680 | Oct 2001 | WO |
WO 2006133030 | Dec 2006 | WO |
WO 2008042987 | Apr 2008 | WO |
WO 2008087613 | Jul 2008 | WO |
WO 2009006335 | Jan 2009 | WO |
WO2009024344 | Feb 2009 | WO |
WO 2009094341 | Jul 2009 | WO |
WO 2009140617 | Nov 2009 | WO |
Entry |
---|
Black et al.; U.S. Appl. No. 12/790,703 entitled “Optical coherence tomography for biological imaging,” filed May 28, 2010. |
Rosenthal et al.; U.S. Appl. No. 12/829,277 entitled “Atherectomy catheter with laterally-displaceable tip,” filed Jul. 1, 2010. |
Spencer et al.; U.S. Appl. No. 12/829,267 entitled “Catheter-based off-axis optical coherence tomography imaging system,” filed Jul. 1, 2010. |
Aziz et al.; Chronic total occlusions—a stiff challege requiring a major breakthrough: is there light at the end of the tunnel?; Heart; vol. 91; suppl. III; pp. 42-48; 2005. |
Olson, William John; U.S. Appl. No. 12/272,697 entitled “Dual-tip Catheter System for Boring through Blocked Vascular Passages,” filed Nov. 17, 2008. |
He et al.; U.S. Appl. No. 12/963,536 entitled “Devices and methods for predicting and preventing restenosis,” filed Dec. 8, 2010. |
Sharma et al.; Optical coherence tomography based on an all-fiber autocorrelator using probe-end reflection as reference; CWJ13; San Francisco, California; CLEO May 16, 2004; 4 pages. |
Han et al.; In situ Frog Retina Imaging Using Common-Path OCT with a Gold-Coated Bare Fiber Probe; CFM6; San Jose, California; CLEO, May 4, 2008; 2 pages. |
Muller et al.; Time-gated infrared fourier-domain optical coherence tomography; CFM5; San Jose, California; CLEO May 4, 2008; 2 pages. |
Wang et al.; Common-path endoscopic Fourier domain OCT with a reference Michelson interferometer; Proceedings of the SPIE; vol. 7566; pp. 75660L-75660L-7; Jan. 2010. |
Simpson et. al; U.S. Appl. No. 13/433,049 entitled “Occlusion-Crossing Devices, Imaging, and Atherectomy Devices,” filed Mar. 28, 2012. |
Emkey et al.; Analysis and evaluation of graded-index fiber-lenses; Journal of Lightwave Technology; vol. LT-5; No. 9; pp. 1156-1164; Sep. 1987. |
Linares et al.; Arbitrary single-mode coupling by tapered and nontapered grin fiber lenses; Applied Optics; vol. 29; No. 28; pp. 4003-4007; Oct. 1, 1990. |
Suparno et al.; Light scattering with singel-mode fiber collimators; Applied Optics; vol. 33; No. 30; pp. 7200-7205; Oct. 20, 1994. |
Patel et al.; U.S. Appl. No. 13/929,579 entitled “Guidewire Positioning Catheter,” filed Jun. 27, 2013. |
Spencer et al.; U.S. Appl. No. 13/939,161 entitled “Catheter-Based Off-Axis Optical Coherence Tomography Imaging System,” filed Jul. 10, 2013. |
He et al.; U.S. Appl. No. 14/019,466 entitled “Devices and Methods for Predicting and Preventing Restenosis,” filed Sep. 5, 2013. |
Number | Date | Country | |
---|---|---|---|
20100274270 A1 | Oct 2010 | US |
Number | Date | Country | |
---|---|---|---|
61173542 | Apr 2009 | US | |
61233093 | Aug 2009 | US |